Polaryx Therapeutics, Inc. (PLYX)
3.39
-0.27
(-7.38%)
USD |
NASDAQ |
May 11, 16:00
3.34
-0.05
(-1.47%)
After-Hours: 20:00
Polaryx Therapeutics Shareholders Equity (Quarterly) : 4.565M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 562.30M |
| Corcept Therapeutics, Inc. | 637.99M |
| Assertio Holdings, Inc. | 75.63M |
| Veru, Inc. | 37.12M |
| IGC Pharma, Inc. | 7.423M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.42M |
| Total Liabilities (Quarterly) | 0.855M |
| Current Ratio | 8.546 |